[Role of erythropoietin deficiency in the pathogenesis of renal anemia].
A review is given of clinical studies performed by use of a highly sensitive in-vitro erythropoietin assay (fetal mouse livercell culture) in large patients' populations to clarify the controversial role of erythropoietin deficiency in the pathogenesis of renal anemia. Studies involved a.) patients with chronic renal disease and varying degree of renal insufficiency in the predialysis phase b.) non-nephrectomized and anephric patients on regular hemodialysis treatment. The data available demonstrate that the initial phase of renal anemia is accompanied by a compensatory increase of serumerythropoietin concentration and therefore erythropoietin deficiency has to be excluded as a primary cause of the anemia of renal failure; merely a relative lack of erythropoietin seems to exist. In the terminal phase of renal failure, erythropoietin deficiency becomes absolute, such in 50% of the investigated non-nephrectomized hemodialysis patients and in all anephric patients. However in individual patients even in terminal renal failure a sustained regulatory feedback mechanism between serumerythropoietin concentration and hematocrit, probably working at lower hematocrit level, could be demonstrated.
D000740:Anemia / Q000097:blood / Q000209:etiology*; D000818:Animals; D002478:Cells, Cultured; D004921:Erythropoietin / Q000032:analysis / Q000172:deficiency*; D006400:Hematocrit; D006801:Humans; D066298:In Vitro Techniques; D007676:Kidney Failure, Chronic / Q000097:blood / Q000209:etiology*; D008099:Liver; D051379:Mice; D014511:Uremia / Q000097:blood / Q000209:etiology
D004921:Erythropoietin
Die Rolle des Erythropoietinmangels in der Pathogenese der renalen Anämie.